Company / Capital Expenditures
OMEROS CORP Capital Expenditures History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$165.0K
FY2024
5-year range
$113.0K / $426.0K
FY2020-FY2024
Trend
-61.3%
vs FY2023
Sector context
#162 of 194
Health Care
What the data says
OMEROS CORP's capital expenditures of $165,000 is lower than 84% of companies in the Health Care sector (FY2024). Capital Expenditures has fluctuated over the past 10 years, ranging from $113,000 in FY2022 to $567,000 in FY2018.
Based on SEC 10-K filings.
$165,000 in FY2024 with a 5-year CAGR of -13.2%.
Improved from $113,000 to $165,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -15.9%
- 5-Year CAGR
- -13.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 194This company $165.0K Sector average $117.5M
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -13.2%, indicating a declining trend.
- In FY2024, capital expenditures decreased 61.3% year-over-year.
- Ranks #162 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $165.0K | -61.3% |
| FY2023 | $426.0K | +277.0% |
| FY2022 | $113.0K | -59.2% |
| FY2021 | $277.0K | -2.1% |
| FY2020 | $283.0K | -15.3% |
| FY2019 | $334.0K | -41.1% |
| FY2018 | $567.0K | +62.0% |
| FY2017 | $350.0K | +177.8% |
| FY2016 | $126.0K | -38.2% |
| FY2015 | $204.0K | +628.6% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026